Animal Models of T‐cell Lymphoma

Hattori, Keiichiro; Shrestha, Raksha; Sakamoto, Tatsuhiro; Kusakabe, Manabu; Sakata‐Yanagimoto, Mamiko

doi:10.1002/9781119671336.ch4

Cited by 1 publication

(1 citation statement)

References 44 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A wide range of preclinical models are being studied in research ranging from primary cultures, cell lines, xenografting, and patient derived xenografting (PDX) to more advanced organoid cultures including the patient-derived organoid (PDO). Due to the diversity and/or heterogeneity found in T-cell malignancy a wide variety of in vivo as well as in vitro models have been established (13,14). Various animal models used in T-cell lymphoma are listed in Table 2.…”

Section: Models For T-cell Lymphoma Studymentioning

confidence: 99%

Junction of the redox dynamic, orchestra of signaling, and altered metabolism in regulation of T- cell lymphoma

Singh

Maurya

2023

Front. Oncol.

View full text Add to dashboard Cite

T-cell lymphoma is a hematologic neoplasm derived from the lymphoid lineage. It belongs to a diverse group of malignant disorders, mostly affecting the young population worldwide, that vary with respect to molecular features as well as genetic and clinical complexities. Cancer cells rewire the cellular metabolism, persuading it to meet new demands of growth and proliferation. Furthermore, the metabolic alterations and heterogeneity are aberrantly driven in cancer by a combination of genetic and non-genetic factors, including the tumor microenvironment. New insight into cancer metabolism highlights the importance of nutrient supply to tumor development and therapeutic responses. Importantly, oxidative stress due to an imbalance in the redox status of reactive species via exogenous and/or endogenous factors is closely related to multiple aspects of cancer. This alters the signaling pathways governed through the multiple intracellular signal transduction and transcription factors, leading to tumor progression. These oncogenic signaling molecules are regulated through different redox sensors, including nuclear factor-erythroid 2 related factor 2 (Nrf2), phase-II antioxidant enzyme, and NQO1 (NADPH quinone oxidoreductase (1). The existing understanding of the molecular mechanisms of T-cell lymphoma regulation through the cross-talk of redox sensors under the influence of metabolic vulnerability is not well explored. This review highlights the role of the redox dynamics, orchestra of signaling, and genetic regulation involved in T-cell lymphoma progression in addition to the challenges to their etiology, treatment, and clinical response in light of recent updates.

show abstract

Section: Models For T-cell Lymphoma Studymentioning

confidence: 99%